Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Hygienic behaviour selection via freeze-killed honey bee brood not associated with chalkbrood resistance in eastern Australia.

Gerdts J, Dewar RL, Simone Finstrom M, Edwards T, Angove M.

PLoS One. 2018 Nov 14;13(11):e0203969. doi: 10.1371/journal.pone.0203969. eCollection 2018.

2.

Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays.

Morrison BJ, Martin NJ, Rehman T, Ewing D, Dewar RL, Metcalf J, Sun P, Beigel J, Luke TC, Raviprakash K.

BMC Health Serv Res. 2018 Aug 22;18(1):651. doi: 10.1186/s12913-018-3465-3.

3.

Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation.

Swaminathan S, Qiu J, Rupert AW, Hu Z, Higgins J, Dewar RL, Stevens R, Rehm CA, Metcalf JA, Sherman BT, Baseler MW, Lane HC, Imamichi T.

PLoS One. 2016 Nov 23;11(11):e0167091. doi: 10.1371/journal.pone.0167091. eCollection 2016.

4.

Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy.

Imamichi H, Dewar RL, Adelsberger JW, Rehm CA, O'Doherty U, Paxinos EE, Fauci AS, Lane HC.

Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):8783-8. doi: 10.1073/pnas.1609057113. Epub 2016 Jul 18.

5.

Tenofovir alafenamide as part of a salvage regimen in a patient with multi-drug resistant HIV and tenofovir-DF-associated renal tubulopathy.

Mikula JM, Manion MM, Maldarelli F, Suarez LM, Norman-Wheeler JF, Ober AG, Dewar RL, Kopp JB, Lane HC, Pau AK.

Antivir Ther. 2016;21(6):553-558. doi: 10.3851/IMP3040. Epub 2016 Mar 8.

6.

Towards Better Precision Medicine: PacBio Single-Molecule Long Reads Resolve the Interpretation of HIV Drug Resistant Mutation Profiles at Explicit Quasispecies (Haplotype) Level.

Huang DW, Raley C, Jiang MK, Zheng X, Liang D, Rehman MT, Highbarger HC, Jiao X, Sherman B, Ma L, Chen X, Skelly T, Troyer J, Stephens R, Imamichi T, Pau A, Lempicki RA, Tran B, Nissley D, Lane HC, Dewar RL.

J Data Mining Genomics Proteomics. 2016 Jan;7(1). pii: 182. Epub 2015 Nov 8.

7.

Plasma interleukin-27 (IL-27) levels are not modulated in patients with chronic HIV-1 infection.

Swaminathan S, Hu Z, Rupert AW, Higgins JM, Dewar RL, Stevens R, Chen Q, Rehm CA, Metcalf JA, Baseler MW, Lane HC, Imamichi T.

PLoS One. 2014 Jun 4;9(6):e98989. doi: 10.1371/journal.pone.0098989. eCollection 2014.

8.

Minimally constrained model of self-organized helical states in reversed-field pinches.

Dennis GR, Hudson SR, Terranova D, Franz P, Dewar RL, Hole MJ.

Phys Rev Lett. 2013 Aug 2;111(5):055003. Epub 2013 Jul 30.

PMID:
23952412
9.

Cerebrospinal fluid HIV-1 compartmentalization in a patient with AIDS and acute varicella-zoster virus meningomyeloradiculitis.

Falcone EL, Adegbulugbe AA, Sheikh V, Imamichi H, Dewar RL, Hammoud DA, Sereti I, Lane HC.

Clin Infect Dis. 2013 Sep;57(5):e135-42. doi: 10.1093/cid/cit356. Epub 2013 May 31.

10.

IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation.

Dai L, Lidie KB, Chen Q, Adelsberger JW, Zheng X, Huang D, Yang J, Lempicki RA, Rehman T, Dewar RL, Wang Y, Hornung RL, Canizales KA, Lockett SJ, Lane HC, Imamichi T.

J Exp Med. 2013 Mar 11;210(3):517-34. doi: 10.1084/jem.20120572. Epub 2013 Mar 4.

11.

Comprehensive analysis of unique cases with extraordinary control over HIV replication.

Mendoza D, Johnson SA, Peterson BA, Natarajan V, Salgado M, Dewar RL, Burbelo PD, Doria-Rose NA, Graf EH, Greenwald JH, Hodge JN, Thompson WL, Cogliano NA, Chairez CL, Rehm CA, Jones S, Hallahan CW, Kovacs JA, Sereti I, Sued O, Peel SA, O'Connell RJ, O'Doherty U, Chun TW, Connors M, Migueles SA.

Blood. 2012 May 17;119(20):4645-55. doi: 10.1182/blood-2011-10-381996. Epub 2012 Apr 5.

12.

Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa.

Dlamini JN, Hu Z, Ledwaba J, Morris L, Maldarelli FM, Dewar RL, Highbarger HC, Somaroo H, Sangweni P, Follmann DA, Pau AK; Phidisa II Study Team.

J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):304-8. doi: 10.1097/QAI.0b013e3182278c29.

13.

Lack of compartmentalization of HIV-1 quasispecies between the gut and peripheral blood compartments.

Imamichi H, Degray G, Dewar RL, Mannon P, Yao M, Chairez C, Sereti I, Kovacs JA.

J Infect Dis. 2011 Jul 15;204(2):309-14. doi: 10.1093/infdis/jir259.

14.

Lack of effect from a previous single dose of nevirapine on virologic and immunologic responses after 6 months of antiretroviral regimens containing either efavirenz or lopinavir-ritonavir.

Dlamini JN, Hu Z, Somaroo H, Highbarger HC, Follmann DA, Dewar RL, Pau AK.

Pharmacotherapy. 2011 Feb;31(2):158-63. doi: 10.1592/phco.31.2.158.

15.

Therapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamics.

Rozenberg L, Haagmans BL, Neumann AU, Chen G, McLaughlin M, Levy-Drummer RS, Masur H, Dewar RL, Ferenci P, Silva M, Viola MS, Polis MA, Kottilil S.

AIDS. 2009 Nov 27;23(18):2439-50. doi: 10.1097/QAD.0b013e32832ff1c0.

16.

Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa.

Imamichi H, Koita O, Dabitao D, Dao S, Ibrah M, Sogoba D, Dewar RL, Berg SC, Jiang MK, Parta M, Washington JA, Polis MA, Lane HC, Tounkara A.

AIDS Res Hum Retroviruses. 2009 Jan;25(1):45-55. doi: 10.1089/aid.2008.0111.

17.

A nonparametric likelihood test for detecting discordance between two measurements with application to censored viral load determinations.

Hu Z, Follmann D, Qin J, Dewar RL, Sangweni P.

Stat Med. 2008 Sep 30;27(22):4489-501. doi: 10.1002/sim.3298.

18.

Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patients.

Nussenblatt V, McLaughlin M, Rehm CA, Lempicki RA, Brann T, Yang J, Proschan M, Highbarger HC, Dewar RL, Imamichi T, Koratich C, Neumann AU, Masur H, Polis MA, Kottilil S.

AIDS Res Hum Retroviruses. 2007 Nov;23(11):1354-9. doi: 10.1089/aid.2007.0091.

PMID:
18184077
19.

Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients.

Neumann A, Polis M, Rozenberg L, Jackson J, Reitano K, McLaughlin M, Koratich C, Dewar R, Masur H, Haagmans B, Kottilil S.

AIDS. 2007 Sep 12;21(14):1855-65.

PMID:
17721093
20.

Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques.

Igarashi T, Iyengar R, Byrum RA, Buckler-White A, Dewar RL, Buckler CE, Lane HC, Kamada K, Adachi A, Martin MA.

J Virol. 2007 Oct;81(20):11549-52. Epub 2007 Aug 1.

21.

Comparison of the abbott 7000 and bayer 340 systems for measurement of hepatitis C virus load.

Highbarger HC, Hu Z, Kottilil S, Metcalf JA, Polis MA, Vasudevachari MB, Lane HC, Dewar RL.

J Clin Microbiol. 2007 Sep;45(9):2808-12. Epub 2007 Jun 27.

23.

Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy.

Palmer S, Boltz V, Maldarelli F, Kearney M, Halvas EK, Rock D, Falloon J, Davey RT Jr, Dewar RL, Metcalf JA, Mellors JW, Coffin JM.

AIDS. 2006 Mar 21;20(5):701-10.

PMID:
16514300
24.

Statistical characterization of the interchange-instability spectrum of a separable ideal-magnetohydrodynamic model system.

Dewar RL, Tatsuno T, Yoshida Z, N├╝hrenberg C, McMillan BF.

Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Dec;70(6 Pt 2):066409. Epub 2004 Dec 27.

PMID:
15697516
25.

Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.

Palmer S, Kearney M, Maldarelli F, Halvas EK, Bixby CJ, Bazmi H, Rock D, Falloon J, Davey RT Jr, Dewar RL, Metcalf JA, Hammer S, Mellors JW, Coffin JM.

J Clin Microbiol. 2005 Jan;43(1):406-13.

26.

New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma.

Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, Polis M, Dewar RL, Planta A, Liu S, Metcalf JA, Mellors JW, Coffin JM.

J Clin Microbiol. 2003 Oct;41(10):4531-6.

27.

Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen.

Polis MA, Suzman DL, Yoder CP, Shen JM, Mican JM, Dewar RL, Metcalf JA, Falloon J, Davey RT Jr, Kovacs JA, Feinberg MB, Masur H, Piscitelli SC.

AIDS. 2003 May 23;17(8):1167-72.

PMID:
12819518
28.

Metamorphosis of plasma turbulence-shear-flow dynamics through a transcritical bifurcation.

Ball R, Dewar RL, Sugama H.

Phys Rev E Stat Nonlin Soft Matter Phys. 2002 Dec;66(6 Pt 2):066408. Epub 2002 Dec 16.

PMID:
12513413
29.

Increasing CD4+ T cells specific for tuberculosis correlate with improved clinical immunity after highly active antiretroviral therapy.

Hengel RL, Allende MC, Dewar RL, Metcalf JA, Mican JM, Lane HC.

AIDS Res Hum Retroviruses. 2002 Sep 1;18(13):969-75.

PMID:
12230939
30.

Quasilinear theory of collisionless Fermi acceleration in a multicusp magnetic confinement geometry.

Dewar RL, Ciubotariu CI.

Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1999 Dec;60(6 Pt B):7400-11.

PMID:
11970687
31.

Up-regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP-responsive element.

Cristillo AD, Highbarger HC, Dewar RL, Dimitrov DS, Golding H, Bierer BE.

FASEB J. 2002 Mar;16(3):354-64.

PMID:
11874984
32.

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters.

Dybul M, Chun TW, Yoder C, Hidalgo B, Belson M, Hertogs K, Larder B, Dewar RL, Fox CH, Hallahan CW, Justement JS, Migueles SA, Metcalf JA, Davey RT, Daucher M, Pandya P, Baseler M, Ward DJ, Fauci AS.

Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15161-6. Epub 2001 Dec 4.

33.

Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy.

Kovacs JA, Vogel S, Metcalf JA, Baseler M, Stevens R, Adelsberger J, Lempicki R, Hengel RL, Sereti I, Lambert L, Dewar RL, Davey RT Jr, Walker RE, Falloon J, Polis MA, Masur H, Lane HC.

Eur J Immunol. 2001 May;31(5):1351-60.

34.

Strong "quantum" chaos in the global ballooning mode spectrum of three-dimensional plasmas.

Dewar RL, Cuthbert P, Ball R.

Phys Rev Lett. 2001 Mar 12;86(11):2321-4.

PMID:
11289919
35.

Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy.

Imamichi H, Crandall KA, Natarajan V, Jiang MK, Dewar RL, Berg S, Gaddam A, Bosche M, Metcalf JA, Davey RT Jr, Lane HC.

J Infect Dis. 2001 Jan 1;183(1):36-50. Epub 2000 Dec 8.

PMID:
11106537
36.

Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients.

Lempicki RA, Kovacs JA, Baseler MW, Adelsberger JW, Dewar RL, Natarajan V, Bosche MC, Metcalf JA, Stevens RA, Lambert LA, Alvord WG, Polis MA, Davey RT, Dimitrov DS, Lane HC.

Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13778-83.

37.

Singularity theory study of overdetermination in models for L-H transitions

Ball R, Dewar RL.

Phys Rev Lett. 2000 Apr 3;84(14):3077-80.

PMID:
11019016
38.

Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression.

Kovacs JA, Imamichi H, Vogel S, Metcalf JA, Dewar RL, Baseler M, Stevens R, Adelsberger J, Lambert L, Davey RT Jr, Walker RE, Falloon J, Polis MA, Masur H, Lane HC.

J Infect Dis. 2000 Oct;182(4):1063-9. Epub 2000 Sep 5.

PMID:
10979900
39.

Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial.

Davey RT Jr, Murphy RL, Graziano FM, Boswell SL, Pavia AT, Cancio M, Nadler JP, Chaitt DG, Dewar RL, Sahner DK, Duliege AM, Capra WB, Leong WP, Giedlin MA, Lane HC, Kahn JO.

JAMA. 2000 Jul 12;284(2):183-9.

PMID:
10889591
40.
41.

Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.

Cohen OJ, Vaccarezza M, Lam GK, Baird BF, Wildt K, Murphy PM, Zimmerman PA, Nutman TB, Fox CH, Hoover S, Adelsberger J, Baseler M, Arthos J, Davey RT Jr, Dewar RL, Metcalf J, Schwartzentruber DJ, Orenstein JM, Buchbinder S, Saah AJ, Detels R, Phair J, Rinaldo C, Margolick JB, Pantaleo G, Fauci AS.

J Clin Invest. 1997 Sep 15;100(6):1581-9.

42.

Improved Particle Confinement Mode in the H-1 Heliac Plasma.

Shats MG, Rudakov DL, Blackwell BD, Borg GG, Dewar RL, Hamberger SM, Howard J, Sharp LE.

Phys Rev Lett. 1996 Nov 11;77(20):4190-4193. No abstract available.

PMID:
10062471
43.

The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection.

Klausner JD, Makonkawkeyoon S, Akarasewi P, Nakata K, Kasinrerk W, Corral L, Dewar RL, Lane HC, Freedman VH, Kaplan G.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Mar 1;11(3):247-57.

PMID:
8603261
44.

Comment on "Radial structure of high-mode-number toroidal modes in general equilibrium profiles"

Dewar RL, Zhang YZ, Mahajan SM.

Phys Rev Lett. 1995 May 29;74(22):4563. No abstract available.

PMID:
10058538
45.

Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma.

Dewar RL, Highbarger HC, Sarmiento MD, Todd JA, Vasudevachari MB, Davey RT Jr, Kovacs JA, Salzman NP, Lane HC, Urdea MS.

J Infect Dis. 1994 Nov;170(5):1172-9.

PMID:
7963710
46.

Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661.

Davey RT Jr, Dewar RL, Reed GF, Vasudevachari MB, Polis MA, Kovacs JA, Falloon J, Walker RE, Masur H, Haneiwich SE, et al.

Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5608-12.

47.

Isolation of HIV-1 from plasma of infected individuals: an analysis of experimental conditions affecting successful virus propagation.

Dewar RL, Sarmiento MD, Lawton ES, Clark HM, Kennedy PE, Shah A, Baseler M, Metcalf JA, Lane HC, Salzman NP.

J Acquir Immune Defic Syndr. 1992;5(8):822-8.

PMID:
1355557
48.
49.
50.

Supplemental Content

Loading ...
Support Center